Background Women are more susceptible than men to several forms of pulmonary
hypertension, but have better survival. Sparse data are available on chronic thromboembolic …

Background The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) is
unknown. Previous studies from the United Kingdom and Spain have reported incidence …

Objectives Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, distinct
pulmonary vascular disease, and therefore, there is a lack of data regarding its clinical …

Background The predominance of chronic thromboembolic pulmonary hypertension
(CTEPH) in females and association of HLA-B* 5201 with CTEPH have been reported in …

Background—Chronic thromboembolic pulmonary hypertension (CTEPH) is often a sequel
of venous thromboembolism with fatal natural history; however, many cases can be cured by …

Objective Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by
one or more of the following features: intraluminal thrombus organization, fibrous stenosis …

Background: The prevalence of pulmonary arterial hypertension (PAH) and chronic
thromboembolic pulmonary hypertension (CTEPH) in the US is largely unknown. Prior …

Abbreviated versions of the risk stratification strategy of the European Society of Cardiology
(ESC)/European Respiratory Society (ERS) pulmonary hypertension guidelines have been …

Objectives To investigate if the pulmonary arterial hypertension (PAH) risk assessment tool
presented in the 2015 ESC/ERS guidelines is valid for patients with chronic thromboembolic …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary
hypertension caused by obstruction and vascular remodelling of pulmonary arteries …